347 related articles for article (PubMed ID: 37222810)
1. Diagnostic applications and therapeutic option of Cascade CRISPR/Cas in the modulation of miRNA in diverse cancers: promises and obstacles.
Alinejad T; Modarressi S; Sadri Z; Hao Z; Chen CS
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9557-9575. PubMed ID: 37222810
[TBL] [Abstract][Full Text] [Related]
2. Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges.
Hussen BM; Rasul MF; Abdullah SR; Hidayat HJ; Faraj GSH; Ali FA; Salihi A; Baniahmad A; Ghafouri-Fard S; Rahman M; Glassy MC; Branicki W; Taheri M
Mil Med Res; 2023 Jul; 10(1):32. PubMed ID: 37460924
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9-mediated noncoding RNA editing in human cancers.
Yang J; Meng X; Pan J; Jiang N; Zhou C; Wu Z; Gong Z
RNA Biol; 2018 Jan; 15(1):35-43. PubMed ID: 29028415
[TBL] [Abstract][Full Text] [Related]
4. Emerging Role of CRISPR/Cas9 Technology for MicroRNAs Editing in Cancer Research.
Aquino-Jarquin G
Cancer Res; 2017 Dec; 77(24):6812-6817. PubMed ID: 29208606
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
[TBL] [Abstract][Full Text] [Related]
6. CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis.
Chambers C; Quan L; Yi G; Esquela-Kerscher A
J Vis Exp; 2022 Apr; (182):. PubMed ID: 35532260
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
Li C; Brant E; Budak H; Zhang B
J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
[TBL] [Abstract][Full Text] [Related]
9. The applications of CRISPR/Cas-mediated microRNA and lncRNA editing in plant biology: shaping the future of plant non-coding RNA research.
Bravo-Vázquez LA; Méndez-García A; Chamu-García V; Rodríguez AL; Bandyopadhyay A; Paul S
Planta; 2023 Dec; 259(2):32. PubMed ID: 38153530
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cas9 technology: As an efficient genome modification tool in the cancer diagnosis and treatment.
Behrouzian Fard G; Ahmadi MH; Gholamin M; Amirfakhrian R; Saberi Teimourian E; Karimi MA; Hosseini Bafghi M
Biotechnol Bioeng; 2024 Feb; 121(2):472-488. PubMed ID: 37986642
[TBL] [Abstract][Full Text] [Related]
11. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/Cas9: a powerful tool for identification of new targets for cancer treatment.
Liu B; Saber A; Haisma HJ
Drug Discov Today; 2019 Apr; 24(4):955-970. PubMed ID: 30849442
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in CRISPR technologies for genome editing.
Song M; Koo T
Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9 for cancer treatment: technology, clinical applications and challenges.
Cheng X; Fan S; Wen C; Du X
Brief Funct Genomics; 2020 May; 19(3):209-214. PubMed ID: 32052006
[TBL] [Abstract][Full Text] [Related]
16. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer.
Wang SW; Gao C; Zheng YM; Yi L; Lu JC; Huang XY; Cai JB; Zhang PF; Cui YH; Ke AW
Mol Cancer; 2022 Feb; 21(1):57. PubMed ID: 35189910
[TBL] [Abstract][Full Text] [Related]
17. Interrogation of Functional miRNA-Target Interactions by CRISPR/Cas9 Genome Engineering.
Michaels YS; Wu Q; Fulga TA
Methods Mol Biol; 2017; 1580():79-97. PubMed ID: 28439828
[TBL] [Abstract][Full Text] [Related]
18. CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool.
Shojaei Baghini S; Gardanova ZR; Abadi SAH; Zaman BA; İlhan A; Shomali N; Adili A; Moghaddar R; Yaseri AF
Cell Mol Biol Lett; 2022 May; 27(1):35. PubMed ID: 35508982
[TBL] [Abstract][Full Text] [Related]
19. Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer.
Zhang H; Qin C; An C; Zheng X; Wen S; Chen W; Liu X; Lv Z; Yang P; Xu W; Gao W; Wu Y
Mol Cancer; 2021 Oct; 20(1):126. PubMed ID: 34598686
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
